GlassScriptPhysician profile
Jonathan M Shults
NPI 1013013101
$6,151.41
in general payments reported to CMS, 2019-2025
27 companies · $1,682 in 2025
The $1,682 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,333 · 2020: $501 · 2021: $408 · 2022: $626 · 2023: $1,242 · 2024: $360 · 2025: $1,682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,804 · Travel and Lodging: $1,479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,804.29 |
| Travel and Lodging | $1,479.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,565.77 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Hat-Trick, Ascension |
| Team 1, LLC | $1,264.27 | 2022-2025 | |
| Arthrex, INC. | $1,001.14 | 2023-2025 | |
| Linvatec Corporation | $277.71 | 2023 | Biobrace 23mm |
| Baudax Bio INC. | $200.58 | 2020-2021 | |
| Axogen | $181.65 | 2019-2023 | Avance Nerve Graft |
| Biorez, INC. | $106.10 | 2022 | |
| Ortho Development Corporation | $73.52 | 2024 | |
| Stryker Corporation | $56.35 | 2023 | Aequalis Perform |
| Sonex Health, INC. | $50.58 | 2020 | |
| Medacta USA, INC. | $47.16 | 2022 | |
| Zyla Life Sciences, INC. | $39.59 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $32.62 | 2021-2022 | |
| Horizon Therapeutics Plc | $31.91 | 2021-2022 | |
| Depuy Synthes Sales INC. | $29.01 | 2023 | Bristow Latarjet, Dynacord, Healix Knotless Peek |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flower Orthopedics Coporation | $24.19 | 2022 | |
| Ibsa Pharma INC. | $22.34 | 2021 | |
| Medtronic USA, INC. | $19.89 | 2019 | |
| Pfizer INC. | $19.66 | 2021 | |
| Bioventus LLC | $17.48 | 2020 | |
| Kci USA, INC. | $14.34 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.83 | 2023 | Seglentis |
| Endo Pharmaceuticals INC. | $13.31 | 2019 | |
| Forte Bio-Pharma LLC | $13.28 | 2021 | |
| Zimmer Biomet Holdings, INC. | $13.10 | 2019 | |
| Vericel Corporation | $11.12 | 2019 | |
| Dynasplint Systems INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Shults listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.